awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43848133-31B8B9CC-42C3-4942-8491-CAFC1FBCF8C5
Q43848133-31B8B9CC-42C3-4942-8491-CAFC1FBCF8C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43848133-31B8B9CC-42C3-4942-8491-CAFC1FBCF8C5
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
P2860
Q43848133-31B8B9CC-42C3-4942-8491-CAFC1FBCF8C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43848133-31B8B9CC-42C3-4942-8491-CAFC1FBCF8C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
14164f50b55879da001ea4039327d699db5101d0
P2860
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.